BACKGROUND: Many HIV-infected patients in the current treatment era have substantial symptom burden, but few HIV palliative care clinics have been described. Our objective was to describe the University of Alabama at Birmingham (UAB) HIV palliative care clinic (HPCC) and compare it to the overall HIV clinic. METHODS: We conducted a chart review of patients referred to the HPCC between April 2008 and June 2011. We evaluated the reason for referral and other issues addressed during palliative care visits. Patient Reported Outcome (PRO) data was used to assess depression (PHQ-9), anxiety (PHQ-A), and substance abuse (ASSIST). RESULTS: Among 124 patients, mean age was 44 (range 27-64), and median CD4 count was 352 cells/mm(3) (IQR 209-639). Depression (43, 35%), anxiety (40, 32%), and current 8 (7%) or prior 68 (56%) substance abuse occurred at higher rates than in the overall HIV clinic (p<0.05). Pain was the most common reason for referral (118, 95%); most was chronic (113, 90%) and included back pain (26, 21%) and neuropathic pain (15, 12%). Other problems commonly addressed by the palliative team included nonpain symptoms such as depression (39, 48%) and anxiety (17, 21%), insomnia (25, 30%), and constipation (26, 32%). CONCLUSIONS: This is the first description of a palliative care clinic embedded within an HIV primary care clinic in a developed country that sees patients at all stages of illness. Chronic pain and nonpain symptom management in patients with psychiatric and substance abuse comorbidities are important components of ambulatory palliative care for HIV-infected patients.
BACKGROUND: Many HIV-infectedpatients in the current treatment era have substantial symptom burden, but few HIV palliative care clinics have been described. Our objective was to describe the University of Alabama at Birmingham (UAB) HIV palliative care clinic (HPCC) and compare it to the overall HIV clinic. METHODS: We conducted a chart review of patients referred to the HPCC between April 2008 and June 2011. We evaluated the reason for referral and other issues addressed during palliative care visits. Patient Reported Outcome (PRO) data was used to assess depression (PHQ-9), anxiety (PHQ-A), and substance abuse (ASSIST). RESULTS: Among 124 patients, mean age was 44 (range 27-64), and median CD4 count was 352 cells/mm(3) (IQR 209-639). Depression (43, 35%), anxiety (40, 32%), and current 8 (7%) or prior 68 (56%) substance abuse occurred at higher rates than in the overall HIV clinic (p<0.05). Pain was the most common reason for referral (118, 95%); most was chronic (113, 90%) and included back pain (26, 21%) and neuropathic pain (15, 12%). Other problems commonly addressed by the palliative team included nonpain symptoms such as depression (39, 48%) and anxiety (17, 21%), insomnia (25, 30%), and constipation (26, 32%). CONCLUSIONS: This is the first description of a palliative care clinic embedded within an HIV primary care clinic in a developed country that sees patients at all stages of illness. Chronic pain and nonpain symptom management in patients with psychiatric and substance abuse comorbidities are important components of ambulatory palliative care for HIV-infectedpatients.
Authors: Jessica S Merlin; Liyi Cen; Amy Praestgaard; Michelle Turner; Aura Obando; Craig Alpert; Sophie Woolston; David Casarett; Jay Kostman; Robert Gross; Ian Frank Journal: J Pain Symptom Manage Date: 2011-11-23 Impact factor: 3.612
Authors: Luke Hansen; Joanne Penko; David Guzman; David R Bangsberg; Christine Miaskowski; Margot B Kushel Journal: J Pain Symptom Manage Date: 2011-07-30 Impact factor: 3.612
Authors: Michael S Kozak; Michael J Mugavero; Jiatao Ye; Inmaculada Aban; Sarah T Lawrence; Christa R Nevin; James L Raper; Cheryl McCullumsmith; Joseph E Schumacher; Heidi M Crane; Mari M Kitahata; Michael S Saag; James H Willig Journal: Clin Infect Dis Date: 2011-10-31 Impact factor: 9.079
Authors: Jessica S Merlin; Andrew O Westfall; James L Raper; Anne Zinski; Wynne E Norton; James H Willig; Robert Gross; Christine S Ritchie; Michael S Saag; Michael J Mugavero Journal: J Acquir Immune Defic Syndr Date: 2012-10-01 Impact factor: 3.731
Authors: Jessica S Merlin; Janet M Turan; Ivan Herbey; Andrew O Westfall; Joanna L Starrels; Stefan G Kertesz; Michael S Saag; Christine S Ritchie Journal: Pain Med Date: 2014-08-19 Impact factor: 3.750
Authors: Jessica S Merlin; Andrew O Westfall; Sonya L Heath; Burel R Goodin; Jesse C Stewart; Robert E Sorge; Jarred Younger Journal: J Acquir Immune Defic Syndr Date: 2017-08-01 Impact factor: 3.731
Authors: Jessica S Merlin; Andrew O Westfall; Eric Chamot; Michael Saag; Melonie Walcott; Christine Ritchie; Stefan Kertesz Journal: AIDS Res Hum Retroviruses Date: 2015-03-12 Impact factor: 2.205